Feb 23 (Reuters) - AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient ...
AbbVie (NYSE: ABBV) today announced a new $380 million investment to build two new active pharmaceutical ingredient (API) manufacturing facilities at its current North Chicago, Illinois, campus. These ...
MUSCAT, FEB 23As Oman advances its ambitions under Oman Vision 2040, the spotlight is increasingly shifting from mere ...
AI-powered RDS orchestration synchronizes AMRs and voice picking to deliver goods-to-person performance at a fraction ...
5d
APi Group Corporation (APG) Presents at Barclays 43rd Annual Industrial Select Conference Transcript
Barclays 43rd Annual Industrial Select Conference February 18, 2026 7:30 AM ESTCompany ParticipantsRussell Becker - ...
Manual cleaning remains essential in biomanufacturing despite automation, requiring risk-assessed control strategies to prevent cross-contamination.
Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting depot injectable treatments, today announced that it will ...
Key TakeawaysDigital twins are ultra-accurate computer-based simulations of complex physical systems used for exploring "what ...
Discusses Portfolio Strategy, Recent Exits, and Focus on Deep Tech and Defense Investments February 18, 2026 4:00 AM ...
Anthropic's Claude Sonnet 4.6 matches Opus 4.6 performance at 1/5th the cost. Released while the India AI Impact Summit is on, it is the important AI model ...
IDT Australia (ASX: IDT) reports improving six-month ops under a new leadership team and realignment strategy; revenue up 20% to $8.4m, EBITDA losses narrowed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results